Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Maintaining momentum mid month requires steady approaches. Discover ways to keep your budget on track mid month and stay aligned with goals.
25,694 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
A top AI firm treads a thin line: warning about AI power while pushing new, powerful tools to market. This raises que...
As SpaceX eyes a potential mega-IPO, a veteran market strategist says the issue could force a broad rotation, unlocki...
A federal judge blocked the Trump-era SNAP limits on soda and candy, delaying a controversial nutrition policy that w...
Kalshi is courting a lofty valuation after a recent funding round, signaling confidence in prediction markets amid a ...
PepsiCo drives growth with international momentum while Procter & Gamble shines in beauty; both set the stage for a d...
Two pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
Kraken has reportedly secured access to the Fed’s core payment systems, a move that could accelerate settlement times...
Artificial intelligence is reshaping how we build and defend crypto networks. Discover the ideas behind AI-assisted v...
A seismic shift is brewing in the card world. Capital One's integration with Discover could turn payment processing i...
Even after a stellar quarter, Micron stock moved lower. This article reveals the secret reason micron stock traders a...
A major institution disclosed a sizable stake in the Akre Focus ETF, signaling strong conviction in a concentrated gr...